Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Philadelphia, Pennsylvania
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Clinical Trials in Philadelphia, Pennsylvania
1 recruiting
Philadelphia, Pennsylvania
Showing
1–1
of
1
trials
Recruiting
Phase 1
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Amgen
60 enrolled
14 locations
NCT07140900
Feedback